<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Colston, Josh M</style></author><author><style face="normal" font="default" size="100%">Devleesschauwer, Brecht</style></author><author><style face="normal" font="default" size="100%">Flynn, Thomas</style></author><author><style face="normal" font="default" size="100%">Schiaffino, Francesca</style></author><author><style face="normal" font="default" size="100%">Revathi, Adhvikaa Ambikapathi</style></author><author><style face="normal" font="default" size="100%">Hossain, Nasif</style></author><author><style face="normal" font="default" size="100%">Chen, Yen Ting</style></author><author><style face="normal" font="default" size="100%">Meister, Danielle</style></author><author><style face="normal" font="default" size="100%">Bagherian, Ava</style></author><author><style face="normal" font="default" size="100%">Binggeli, Olivia</style></author><author><style face="normal" font="default" size="100%">Zheng, Emily</style></author><author><style face="normal" font="default" size="100%">David, Nhiya</style></author><author><style face="normal" font="default" size="100%">Scallan Walter, Elaine</style></author><author><style face="normal" font="default" size="100%">Kirk, Martyn D</style></author><author><style face="normal" font="default" size="100%">Di Bari, Carlotta</style></author><author><style face="normal" font="default" size="100%">Lake, Robin</style></author><author><style face="normal" font="default" size="100%">Havelaar, Arie H</style></author><author><style face="normal" font="default" size="100%">Pires, Sara M</style></author><author><style face="normal" font="default" size="100%">Robertson, Lucy J</style></author><author><style face="normal" font="default" size="100%">Minato, Yuki</style></author><author><style face="normal" font="default" size="100%">Majowicz, Shannon E.</style></author><author><style face="normal" font="default" size="100%">Kosek, Margaret N</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Updated Estimates of the Global, Regional and National Burden, and Etiology of Diarrheal Diseases Transmissible via Food: A Systematic Review and Meta-Analytical Modelling Study for the World Health Organization</style></title><secondary-title><style face="normal" font="default" size="100%">medRxiv</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-01-01 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">2026.01.26.26344508</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.64898/2026.01.26.26344508</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">Diarrheal disease is caused by diverse species of viruses, bacteria and protozo that are transmitted from different sources, including from contaminated food. Sustaining progress in reducing diarrheal illnesses and deaths, including vaccines and food safety measures, may require interventions targeting specific pathogens. In 2015, the WHO’s published etiology-specific estimates by their Foodborne Disease Burden Epidemiology Reference Group (FERG) of the incidence and mortality of diarrheal diseases caused by 11 pathogens at global and regional scales in 2010. Since then, much new evidence has been published about the epidemiology of enteropathogens. This study aims to update estimates to the year 2021 with the addition of three pathogens (Rotavirus, Cyclospora cayetanensis, Enteroaggregative E. coli (EAEC)). For low- and middle-income countries (LMICs), we conducted a systematic review of publications that reported the prevalence of pathogens diagnosed in stool samples from asymptomatic subjects, community-detected and outpatient diarrhea cases, and those treated as inpatients. Hierarchical, mixed effects models were fitted to pathogen-specific prevalence data extracted from studies that met prespecified inclusion criteria, and population attributable fractions (PAF) were calculated from the model parameter estimates, adjusting for background asymptomatic transmission where appropriate. The PAFs were applied to previously estimated diarrhea incidence and mortality envelopes. A separate, parallel systematic review identified studies that estimated diarrhea incidence and mortality due to specific etiologies for high income countries (HICs) from surveillance data. Meta-analytical models were fitted to data extracted from these. Data from 324 studies published between 1990 and 2023 representing results from up to 540,000 samples were used in the meta-analysis. Globally the 14 pathogens were responsible for 2.2 billion diarrheal disease cases and 880,000 deaths in 2021, with the largest number of cases occurring in South-East Asia, the largest number of deaths in Sub-Saharan Africa, and Europe being the region with the lowest burden by both measures. We found the leading causes of diarrhea morbidity to be bacteria – Shigella (426.4 million cases in 2021), Campylobacter (291.4 million) and ETEC (259.7 million)) – as well as the protozoon Giardia (321.2 million), in contrast to previous studies that have ranked rotavirus and norovirus highest. Our estimates support a much higher morbidity burden for Shigella than previously estimated with an incidence rate for 2021 (5,400 per 100,000). This is due to its high PAF in outpatients aged ≥5 years. As causes of diarrhea mortality, our estimates rank rotavirus first (214,700 deaths in 2021), Shigella second (152,500), and V. cholerae (94,100) third, due to the latter’s large PAF in inpatients aged ≥5 years and high case fatality rate. Caution is urged when interpreting PAFs for pathogens that elicit prolonged residual shedding following resolution of symptoms (e.g., norovirus, Campylobacter, Giardia). These findings, derived from rigorous systematic review and statistical methodologies and the largest database yet compiled of pathogen detection rates, will serve as inputs for the WHO’s broader estimates of hazard-specific incidence and mortality from foodborne diseases and are made available to the research and policy-making communities to inform targeted strategies for global diarrheal disease control.Funding: WHO EDTF_001; 1K01AI168493-01A1; K43TW012298; 5T32AI007046-48.Competing Interest StatementIn addition to funding disclosed elsewhere, the authors report the following interests: Grants and Contracts: the Canadian Institutes for Health Research, National Science and Engineering Research Council, and Bill &amp; Melinda Gates Foundation and the UK's Department for International Development (Majowicz); the European Food Safety Agency (Devleesschauwer, Di Bari); New Zealand Institute of Public Health and Forensic Science (Lake); the Norwegian Research Council, Nestle, and water providers in Norway (Robertson); and the U.S. Centers for Disease Control and Prevention, U.S. Department of Agriculture, Colorado Department of Public Health and Environment, Human Resources and Services Administration, National Network of Public Health Institutes, and the Council for State and Territorial Epidemiologists (Scallan Walter). Support for attending meetings/travel: Food and Agriculture Organization of the United Nations (FAO), European Federation of Parasitology, and DISCONTOOLS (https://www.discontools.eu/; Robertson). Participation on Data Safety Monitoring Boards or Advisory Boards: New Zealand Food Safety (Lake); and the Norwegian Scientific Committee of Food Safety and the Environment (Robertson). Consulting Fees: Western University (Majowicz); the World Health Organization (Havelaar); and Moderna (Kosek). Leadership or fiduciary role in a board, society, committee or advocacy group: FAO Expert Meeting on Foodborne Helminths, and the European Federation of Parasitologists (Robertson).Clinical Protocols https://bmjopen.bmj.com/content/15/4/e093018 https://www.crd.york.ac.uk/PROSPERO/view/CRD42023427998 Funding StatementThe WHO commissioned and funded new systematic reviews to provide the data used in this analysis through contracts to the University of Virginia School of Medicine (WHO EDTF_001 to MNK) and the Colorado School of Public Health (WHO EDTF_001 to ESW), as well as salary support for the data analysts at Sciensano who did the computations for this work. JMC was also supported by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (1K01AI168493-01A1). FS was supported by K43TW012298; TGF receives support from the Infectious Diseases Training Programme at the University of Virginia (5T32AI007046-48). NH was supported by the UVA Environmental Institute through the Strategic Investment Fund. MNK obtained additional support from the University of Virginia.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All human subject information used was aggregated secondary data. For studies for which individual level microdata was used, these were either already shared with the authors under data use agreements and used with specific permission for this purpose, or otherwise publicly available. We followed the PRISMA, GATHER and STROBOD guidelines (supplementary file S2).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesA database of our full estimates stratified by year, age group, sex, country, and burden indicator, as well as the PAFs in figure 3, is available as supplementary file S3. The extracted data to which models were fitted is available upon reasonable request to the communicating author.</style></abstract></record></records></xml>